ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer
Turan Tufan(University of Virginia), Mazhar Adli(University of Virginia)
Cited by 2
Related Papers
Genomewide Analysis of PRC1 and PRC2 Occupancy Identifies Two Classes of Bivalent Domains
|PLoS Genetics|2008|1k
Endometriosis and adenomyosis: shared pathophysiology
|Fertility and Sterility|2023|195
IKKα and IKKβ Each Function to Regulate NF-κB Activation in the TNF-Induced/Canonical Pathway
|PLoS ONE|2010|116
Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells
|Proceedings of the National Academy of Sciences|2020|113